Sponsored · Whitepaper

Managing Third-Party Risks Across Your Life Sciences Business

Leveraging third parties is a key business growth strategy and is increasing in the life sciences sector as these partnerships help pharmaceutical, medical device, and biotechnology companies complete important research and clinical trials as well as commercialize, manufacture, and distribute products. Often, these relationships provide greater process efficiencies, operational effectiveness, and cost savings by shifting noncore functions to more specialized third-party providers.

Download Now

Also available for download: Bribery and Corruption in the Life Sciences Sector

This whitepaper explores many of the key factors related to third party relationship management for life sciences organizations, including:

  • Security and privacy
  • Anti-bribery
  • Contract compliance
  • Fraud
  • Regulatory compliance
  • Mergers and acquisitions
  • Technology solutions
  • Process improvement

Trending on Xconomy